إعلان
إعلان

BBNX

BBNX logo

Beta Bionics, Inc. Common Stock

20.06
USD
برعاية
-11.93
-37.30%
٠٩ يناير, ١٥:٥٩ UTC -5
مغلق
exchange

بعد الإغلاق

20.50

+0.45
+2.22%

تقارير أرباح BBNX

النسبة الإيجابية المفاجئة

BBNX تفوق 2 من 4 آخر التقديرات.

50%

التقرير التالي

بيانات التقرير القادم
٢٣ مارس ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
$29.48M
/
-$0.41
التغير الضمني من Q3 25 (Revenue/ EPS)
+8.18%
/
+24.24%
التغير الضمني من Q4 24 (Revenue/ EPS)
+44.24%
/
-84.93%

Beta Bionics, Inc. Common Stock earnings per share and revenue

On ٢٨ أكتوبر ٢٠٢٥, BBNX reported earnings of -0.33 USD per share (EPS) for Q3 25, beating the estimate of -0.44 USD, resulting in a 25.39% surprise. Revenue reached 27.25 مليون, compared to an expected 24.45 مليون, with a 11.46% difference. The market reacted with a +10.34% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 12 المحللين forecast an EPS of -0.41 USD, with revenue projected to reach 29.48 مليون USD, implying an زيادة of 24.24% EPS, and زيادة of 8.18% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
AngioDynamics, Inc.
Report Date
٠٦ يناير ٢٠٢٦ إلى ربع سنوي2 26
تقدير
-$0.10
الفعلي
$0.00
مفاجئة
+100.00%
الأسئلة الشائعة
For Q3 2025, Beta Bionics, Inc. Common Stock reported EPS of -$0.33, beating estimates by 25.39%, and revenue of $27.25M, 11.46% above expectations.
The stock price moved up 10.34%, changed from $24.28 before the earnings release to $26.79 the day after.
The next earning report is scheduled for ٢٣ مارس ٢٠٢٦.
Based on 12 المحللين, Beta Bionics, Inc. Common Stock is expected to report EPS of -$0.41 and revenue of $29.48M for Q4 2025.
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان